Catabasis Pharmaceuticals Lands $445,865 New Financing

  • Feed Type
  • Date
    6/27/2013
  • Company Name
    Catabasis Pharmaceuticals
  • Mailing Address
    One Kendall Square Bldg. 1400E Cambridge, MA 02139
  • Company Description
    At Catabasis we are dedicated to the discovery and development of innovative, effective and safe medicines to treat inflammatory and metabolic diseases. We have assembled a team of highly motivated and experienced scientists who are committed to improving the lives of patients.
  • Website
    http://www.catabasispharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $445,865
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing – amended.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.